Altrius Capital Management Inc raised its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 6.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,416 shares of the health services provider's stock after purchasing an additional 856 shares during the quarter. Altrius Capital Management Inc's holdings in The Cigna Group were worth $3,981,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently modified their holdings of the stock. Collier Financial acquired a new stake in The Cigna Group in the 4th quarter valued at $32,000. ORG Wealth Partners LLC bought a new position in shares of The Cigna Group during the fourth quarter valued at $34,000. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group in the 3rd quarter valued at $37,000. Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group in the 4th quarter worth about $37,000. Finally, Harbor Capital Advisors Inc. acquired a new stake in shares of The Cigna Group during the 3rd quarter worth about $45,000. 86.99% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
CI has been the topic of a number of recent analyst reports. Barclays reduced their price target on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating on the stock in a research report on Friday, January 31st. UBS Group reduced their target price on The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada set a $355.00 price target on The Cigna Group in a report on Friday, January 31st. Wells Fargo & Company reduced their price objective on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research note on Tuesday, February 4th. Finally, Morgan Stanley decreased their target price on The Cigna Group from $403.00 to $379.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $372.31.
Check Out Our Latest Report on CI
The Cigna Group Stock Down 0.8 %
Shares of CI traded down $2.61 on Tuesday, hitting $308.90. The company's stock had a trading volume of 1,545,750 shares, compared to its average volume of 1,846,756. The firm's fifty day moving average price is $290.14 and its 200-day moving average price is $318.34. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $85.92 billion, a price-to-earnings ratio of 25.24, a P/E/G ratio of 0.98 and a beta of 0.54.
The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the firm posted $6.79 earnings per share. On average, equities research analysts expect that The Cigna Group will post 29.77 EPS for the current year.
The Cigna Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date is Wednesday, March 5th. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. The Cigna Group's dividend payout ratio is 49.35%.
The Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles

Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.